<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38066589</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2051-5960</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>08</Day></PubDate></JournalIssue><Title>Acta neuropathologica communications</Title><ISOAbbreviation>Acta Neuropathol Commun</ISOAbbreviation></Journal><ArticleTitle>Post-COVID exercise intolerance is associated with capillary alterations and immune dysregulations in skeletal muscles.</ArticleTitle><Pagination><StartPage>193</StartPage><MedlinePgn>193</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">193</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40478-023-01662-2</ELocationID><Abstract><AbstractText>The SARS-CoV-2 pandemic not only resulted in millions of acute infections worldwide, but also in many cases of post-infectious syndromes, colloquially referred to as "long COVID". Due to the heterogeneous nature of symptoms and scarcity of available tissue samples, little is known about the underlying mechanisms. We present an in-depth analysis of skeletal muscle biopsies obtained from eleven patients suffering from enduring fatigue and post-exertional malaise after an infection with SARS-CoV-2. Compared to two independent historical control cohorts, patients with post-COVID exertion intolerance had fewer capillaries, thicker capillary basement membranes and increased numbers of CD169<sup>+</sup> macrophages. SARS-CoV-2 RNA could not be detected in the muscle tissues. In addition, complement system related proteins were more abundant in the serum of patients with PCS, matching observations on the transcriptomic level in the muscle tissue. We hypothesize that the initial viral infection may have caused immune-mediated structural changes of the microvasculature, potentially explaining the exercise-dependent fatigue and muscle pain.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aschman</LastName><ForeName>Tom</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-2101-6146</Identifier><AffiliationInfo><Affiliation>Department of Neuropathology, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, corporate member of Freie Universit&#xe4;t Berlin, Humboldt Universit&#xe4;t zu Berlin, Berlin Institute of Health, Berlin, Germany. tom.aschman@charite.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wyler</LastName><ForeName>Emanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Max Delbr&#xfc;ck Center for Molecular Medicine, Berlin Institute for Medical Systems Biology, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baum</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Institute of Physiology, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, corporate member of Freie Universit&#xe4;t Berlin, Humboldt Universit&#xe4;t zu Berlin, Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hentschel</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Leibniz-Institut F&#xfc;r Analytische Wissenschaften - ISAS - E.V, Dortmund, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rust</LastName><ForeName>Rebekka</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Experimental and Clinical Research Center and NeuroCure Clinical Research Center, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, corporate member of Freie Universit&#xe4;t Berlin, Humboldt Universit&#xe4;t zu Berlin, Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Immunology, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, corporate member of Freie Universit&#xe4;t Berlin, Humboldt Universit&#xe4;t zu Berlin, Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Legler</LastName><ForeName>Franziska</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Experimental and Clinical Research Center and NeuroCure Clinical Research Center, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, corporate member of Freie Universit&#xe4;t Berlin, Humboldt Universit&#xe4;t zu Berlin, Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Preusse</LastName><ForeName>Corinna</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neuropathology, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, corporate member of Freie Universit&#xe4;t Berlin, Humboldt Universit&#xe4;t zu Berlin, Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, corporate member of Freie Universit&#xe4;t Berlin, Humboldt Universit&#xe4;t zu Berlin, Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyer-Arndt</LastName><ForeName>Lil</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Experimental and Clinical Research Center and NeuroCure Clinical Research Center, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, corporate member of Freie Universit&#xe4;t Berlin, Humboldt Universit&#xe4;t zu Berlin, Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xfc;ttnerova</LastName><ForeName>Ivana</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Autoimmune Diagnostics, Labor Berlin-Charit&#xe9; Vivantes GmbH, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>F&#xf6;rster</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neuropathology, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, corporate member of Freie Universit&#xe4;t Berlin, Humboldt Universit&#xe4;t zu Berlin, Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cengiz</LastName><ForeName>Derya</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical Faculty, Heinrich-Heine-University, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alves</LastName><ForeName>Luiz Gustavo Teixeira</ForeName><Initials>LGT</Initials><AffiliationInfo><Affiliation>Max Delbr&#xfc;ck Center for Molecular Medicine, Berlin Institute for Medical Systems Biology, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Virology, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, corporate member of Freie Universit&#xe4;t Berlin, Humboldt Universit&#xe4;t zu Berlin, Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kedor</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Medical Immunology, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, corporate member of Freie Universit&#xe4;t Berlin, Humboldt Universit&#xe4;t zu Berlin, Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellmann-Strobl</LastName><ForeName>Judith</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Experimental and Clinical Research Center and NeuroCure Clinical Research Center, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, corporate member of Freie Universit&#xe4;t Berlin, Humboldt Universit&#xe4;t zu Berlin, Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanchin</LastName><ForeName>Aminaa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, corporate member of Freie Universit&#xe4;t Berlin, Humboldt Universit&#xe4;t zu Berlin, Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goebel</LastName><ForeName>Hans-Hilmar</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>Department of Neuropathology, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, corporate member of Freie Universit&#xe4;t Berlin, Humboldt Universit&#xe4;t zu Berlin, Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuropathology, Universit&#xe4;tsmedizin Mainz, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landthaler</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Max Delbr&#xfc;ck Center for Molecular Medicine, Berlin Institute for Medical Systems Biology, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Biology, Humboldt-Universit&#xe4;t zu Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corman</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institute of Virology, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, corporate member of Freie Universit&#xe4;t Berlin, Humboldt Universit&#xe4;t zu Berlin, Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roos</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatric Neurology, Faculty of Medicine, University Children's Hospital, University of Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology Bergmannsheil, Heimer-Institut F&#xfc;r Muskelforschung am Bergmannsheil, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heppner</LastName><ForeName>Frank L</ForeName><Initials>FL</Initials><AffiliationInfo><Affiliation>Department of Neuropathology, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, corporate member of Freie Universit&#xe4;t Berlin, Humboldt Universit&#xe4;t zu Berlin, Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cluster of Excellence, NeuroCure, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radbruch</LastName><ForeName>Helena</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neuropathology, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, corporate member of Freie Universit&#xe4;t Berlin, Humboldt Universit&#xe4;t zu Berlin, Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paul</LastName><ForeName>Friedemann</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Experimental and Clinical Research Center and NeuroCure Clinical Research Center, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, corporate member of Freie Universit&#xe4;t Berlin, Humboldt Universit&#xe4;t zu Berlin, Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Max Delbrueck Center for Molecular Medicine, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scheibenbogen</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Medical Immunology, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, corporate member of Freie Universit&#xe4;t Berlin, Humboldt Universit&#xe4;t zu Berlin, Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Dengler</LastName><ForeName>Nora F</ForeName><Initials>NF</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, corporate member of Freie Universit&#xe4;t Berlin, Humboldt Universit&#xe4;t zu Berlin, Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Stenzel</LastName><ForeName>Werner</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neuropathology, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, corporate member of Freie Universit&#xe4;t Berlin, Humboldt Universit&#xe4;t zu Berlin, Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>KA1-Co-02 'COVIPA'</GrantID><Agency>Helmholtz association Initiative and Networking Fund grant</Agency><Country/></Grant><Grant><GrantID>KA1-Co-02 'COVIPA'</GrantID><Agency>Helmholtz association Initiative and Networking Fund grant</Agency><Country/></Grant><Grant><GrantID>KA1-Co-02 'COVIPA'</GrantID><Agency>Helmholtz Association Initiative and Networking Fund grant</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Neuropathol Commun</MedlineTA><NlmUniqueID>101610673</NlmUniqueID><ISSNLinking>2051-5960</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002196" MajorTopicYN="Y">Capillaries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Basement membrane thickening</Keyword><Keyword MajorTopicYN="N">ME/CFS</Keyword><Keyword MajorTopicYN="N">Microangiopathy</Keyword><Keyword MajorTopicYN="N">Post-COVID syndrome</Keyword><Keyword MajorTopicYN="N">Post-acute sequelae of COVID-19 (PASC)</Keyword><Keyword MajorTopicYN="N">Post-infectious syndrome</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>NFD accepted speaker honoraria of Integra LifeSciences and serves as advisor for Alexion Pharmaceuticals. All other authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>17</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>9</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>9</Day><Hour>0</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38066589</ArticleId><ArticleId IdType="pmc">PMC10704838</ArticleId><ArticleId IdType="doi">10.1186/s40478-023-01662-2</ArticleId><ArticleId IdType="pii">10.1186/s40478-023-01662-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>O'Sullivan O. Long-term sequelae following previous coronavirus epidemics. Clin Med. 2021;21(1):e68&#x2013;e70. doi: 10.7861/clinmed.2020-0204.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0204</ArticleId><ArticleId IdType="pmc">PMC7850177</ArticleId><ArticleId IdType="pubmed">33144403</ArticleId></ArticleIdList></Reference><Reference><Citation>Isaacs R. Chronic infectious mononucleosis. Blood. 1948;3(8):858&#x2013;861. doi: 10.1182/blood.V3.8.858.858.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V3.8.858.858</ArticleId><ArticleId IdType="pubmed">18873530</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson DA, Shelokov A. Epidemic neuromyasthenia; clinical syndrome. N Engl J Med. 1959;260(16):814&#x2013;818. doi: 10.1056/NEJM195904162601606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM195904162601606</ArticleId><ArticleId IdType="pubmed">13644592</ArticleId></ArticleIdList></Reference><Reference><Citation>Seet RC, Quek AM, Lim EC. Post-infectious fatigue syndrome in dengue infection. J Clin Virol. 2007;38(1):1&#x2013;6. doi: 10.1016/j.jcv.2006.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2006.10.011</ArticleId><ArticleId IdType="pubmed">17137834</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnus P, et al. Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine. Vaccine. 2015;33(46):6173&#x2013;6177. doi: 10.1016/j.vaccine.2015.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.10.018</ArticleId><ArticleId IdType="pubmed">26475444</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartung TJ, et al. Fatigue and cognitive impairment after COVID-19: a prospective multicentre study. EClinicalMedicine. 2022;53:101651. doi: 10.1016/j.eclinm.2022.101651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101651</ArticleId><ArticleId IdType="pmc">PMC9482331</ArticleId><ArticleId IdType="pubmed">36133318</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Committee for the, C.S.G., et al. (2021) Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA 325(15): 1525&#x2013;1534</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med. 2021;9(11):1275&#x2013;1287. doi: 10.1016/S2213-2600(21)00383-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahmer T, et al. Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: a prospective, multi-centre, population-based cohort study. EClinicalMedicine. 2022;51:101549. doi: 10.1016/j.eclinm.2022.101549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101549</ArticleId><ArticleId IdType="pmc">PMC9289961</ArticleId><ArticleId IdType="pubmed">35875815</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37. doi: 10.1186/1471-2377-11-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-37</ArticleId><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam MH, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009;169(22):2142&#x2013;2147. doi: 10.1001/archinternmed.2009.384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2009.384</ArticleId><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C, et al. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat Commun. 2022;13(1):5104. doi: 10.1038/s41467-022-32507-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32507-6</ArticleId><ArticleId IdType="pmc">PMC9426365</ArticleId><ArticleId IdType="pubmed">36042189</ArticleId></ArticleIdList></Reference><Reference><Citation>Retornaz F, et al. Long-term neuromuscular consequences of SARS-Cov-2 and their similarities with myalgic encephalomyelitis/chronic fatigue syndrome: results of the retrospective CoLGEM study. J Transl Med. 2022;20(1):429. doi: 10.1186/s12967-022-03638-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03638-7</ArticleId><ArticleId IdType="pmc">PMC9509619</ArticleId><ArticleId IdType="pubmed">36153556</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukocheva OA, et al. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome. J Adv Res. 2022;40:179&#x2013;196. doi: 10.1016/j.jare.2021.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jare.2021.11.013</ArticleId><ArticleId IdType="pmc">PMC8619886</ArticleId><ArticleId IdType="pubmed">36100326</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, et al. COVID-19 symptoms over time: comparing long-haulers to ME/CFS. Fatigue. 2021;9(2):59&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8411893</ArticleId><ArticleId IdType="pubmed">34484973</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr JR, et al. Seven genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis: a detailed analysis of gene networks and clinical phenotypes. J Clin Pathol. 2008;61(6):730&#x2013;739. doi: 10.1136/jcp.2007.053553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.2007.053553</ArticleId><ArticleId IdType="pubmed">18057078</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine PH, et al. Clinical, epidemiologic, and virologic studies in four clusters of the chronic fatigue syndrome. Arch Intern Med. 1992;152(8):1611&#x2013;1616. doi: 10.1001/archinte.1992.00400200049009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.1992.00400200049009</ArticleId><ArticleId IdType="pubmed">1323246</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International chronic fatigue syndrome study group. Ann Intern Med. 1994;121(12):953&#x2013;959. doi: 10.7326/0003-4819-121-12-199412150-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType="pubmed">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Vyas J, et al. Impact of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) on the quality of life of people with ME/CFS and their partners and family members: an online cross-sectional survey. BMJ Open. 2022;12(5):e058128. doi: 10.1136/bmjopen-2021-058128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-058128</ArticleId><ArticleId IdType="pmc">PMC9062824</ArticleId><ArticleId IdType="pubmed">35501074</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I, et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. 2006;333(7568):575. doi: 10.1136/bmj.38933.585764.AE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38933.585764.AE</ArticleId><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacerda EM, et al. A logistic regression analysis of risk factors in ME/CFS pathogenesis. BMC Neurol. 2019;19(1):275. doi: 10.1186/s12883-019-1468-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-019-1468-2</ArticleId><ArticleId IdType="pmc">PMC6839177</ArticleId><ArticleId IdType="pubmed">31699051</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa S, et al. Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) J Transl Med. 2018;16(1):268. doi: 10.1186/s12967-018-1644-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1644-y</ArticleId><ArticleId IdType="pmc">PMC6167797</ArticleId><ArticleId IdType="pubmed">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai SY, et al. Increased risk of chronic fatigue syndrome following herpes zoster: a population-based study. Eur J Clin Microbiol Infect Dis. 2014;33(9):1653&#x2013;1659. doi: 10.1007/s10096-014-2095-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-014-2095-x</ArticleId><ArticleId IdType="pubmed">24715153</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchwald D, et al. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection. Ann Intern Med. 1992;116(2):103&#x2013;113. doi: 10.7326/0003-4819-116-2-103.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-116-2-103</ArticleId><ArticleId IdType="pubmed">1309285</ArticleId></ArticleIdList></Reference><Reference><Citation>Shikova E, et al. Cytomegalovirus, Epstein-Barr virus, and human herpesvirus-6 infections in patients with myalgic small ie, Cyrillicncephalomyelitis/chronic fatigue syndrome. J Med Virol. 2020;92(12):3682&#x2013;3688. doi: 10.1002/jmv.25744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25744</ArticleId><ArticleId IdType="pmc">PMC7687071</ArticleId><ArticleId IdType="pubmed">32129496</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr JR, et al. Chronic fatigue syndrome and arthralgia following parvovirus B19 infection. J Rheumatol. 2002;29(3):595&#x2013;602.</Citation><ArticleIdList><ArticleId IdType="pubmed">11911112</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh J, et al. Skeletal muscle and peripheral nerve histopathology in COVID-19. Neurology. 2021;97(8):e849&#x2013;e858. doi: 10.1212/WNL.0000000000012344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000012344</ArticleId><ArticleId IdType="pubmed">34099523</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschman T, et al. Association between SARS-CoV-2 infection and immune-mediated myopathy in patients who have died. JAMA Neurol. 2021;78(8):948&#x2013;960. doi: 10.1001/jamaneurol.2021.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.2004</ArticleId><ArticleId IdType="pubmed">34115106</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall JC, Murthy S, Diaz J, Adhikari NK, Angus DC, Arabi YM, Baillie K, Bauer M, Berry S, Blackwood B, Bonten M. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020;20(8):e192&#x2013;e197. doi: 10.1016/S1473-3099(20)30483-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30483-7</ArticleId><ArticleId IdType="pmc">PMC7292605</ArticleId><ArticleId IdType="pubmed">32539990</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, et al. Myalgic encephalomyelitis: international consensus criteria. J Intern Med. 2011;270(4):327&#x2013;338. doi: 10.1111/j.1365-2796.2011.02428.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType="pmc">PMC3427890</ArticleId><ArticleId IdType="pubmed">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakel B, et al. Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME/CFS. J Transl Med. 2021;19(1):159. doi: 10.1186/s12967-021-02774-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-02774-w</ArticleId><ArticleId IdType="pmc">PMC8056497</ArticleId><ArticleId IdType="pubmed">33874961</ArticleId></ArticleIdList></Reference><Reference><Citation>Cazzoletti L, et al. Six-minute walk distance in healthy subjects: reference standards from a general population sample. Respir Res. 2022;23(1):83. doi: 10.1186/s12931-022-02003-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-022-02003-y</ArticleId><ArticleId IdType="pmc">PMC8985335</ArticleId><ArticleId IdType="pubmed">35382813</ArticleId></ArticleIdList></Reference><Reference><Citation>Cella M, Chalder T. Measuring fatigue in clinical and community settings. J Psychosom Res. 2010;69(1):17&#x2013;22. doi: 10.1016/j.jpsychores.2009.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2009.10.007</ArticleId><ArticleId IdType="pubmed">20630259</ArticleId></ArticleIdList></Reference><Reference><Citation>Framework IC, The MOS. 36-item short-form health survey (SF-36) Med Care. 1992;30(6):473&#x2013;483. doi: 10.1097/00005650-199206000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005650-199206000-00002</ArticleId><ArticleId IdType="pubmed">1593914</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinz A, et al. The quality of life questionnaire EQ-5D-5L: psychometric properties and normative values for the general German population. Qual Life Res. 2014;23(2):443&#x2013;447. doi: 10.1007/s11136-013-0498-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-013-0498-2</ArticleId><ArticleId IdType="pubmed">23921597</ArticleId></ArticleIdList></Reference><Reference><Citation>Leidl R, Reitmeir P. An experience-based value set for the EQ-5D-5L in Germany. Value Health. 2017;20(8):1150&#x2013;1156. doi: 10.1016/j.jval.2017.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2017.04.019</ArticleId><ArticleId IdType="pubmed">28964448</ArticleId></ArticleIdList></Reference><Reference><Citation>Zung WW. A self-rating depression scale. Arch Gen Psychiatry. 1965;12:63&#x2013;70. doi: 10.1001/archpsyc.1965.01720310065008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpsyc.1965.01720310065008</ArticleId><ArticleId IdType="pubmed">14221692</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, et al. Quantitative T2 mapping accelerated by GRAPPATINI for evaluation of muscles in patients with myositis. Br J Radiol. 2019;92(1102):20190109. doi: 10.1259/bjr.20190109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1259/bjr.20190109</ArticleId><ArticleId IdType="pmc">PMC6774592</ArticleId><ArticleId IdType="pubmed">31287733</ArticleId></ArticleIdList></Reference><Reference><Citation>Ran J, et al. T2 mapping in dermatomyositis/polymyositis and correlation with clinical parameters. Clin Radiol. 2018;73(12):1057. doi: 10.1016/j.crad.2018.07.106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.crad.2018.07.106</ArticleId><ArticleId IdType="pubmed">30172348</ArticleId></ArticleIdList></Reference><Reference><Citation>Ai T, et al. Diffusion tensor imaging in evaluation of thigh muscles in patients with polymyositis and dermatomyositis. Br J Radiol. 2014;87(1043):20140261. doi: 10.1259/bjr.20140261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1259/bjr.20140261</ArticleId><ArticleId IdType="pmc">PMC4207168</ArticleId><ArticleId IdType="pubmed">25183381</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, et al. Simultaneous multislice accelerated diffusion tensor imaging of thigh muscles in myositis. AJR Am J Roentgenol. 2018;211(4):861&#x2013;866. doi: 10.2214/AJR.17.19318.</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/AJR.17.19318</ArticleId><ArticleId IdType="pubmed">30085833</ArticleId></ArticleIdList></Reference><Reference><Citation>Martel-Duguech L, et al. Thigh muscle fat infiltration is associated with impaired physical performance despite remission in cushing's syndrome. J Clin Endocrinol Metab. 2020;105(5):e2039. doi: 10.1210/clinem/dgz329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgz329</ArticleId><ArticleId IdType="pubmed">31912154</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller S, et al. Diffusion tensor imaging combined with T2 mapping to quantify changes in the skeletal muscle associated with training and endurance exercise in competitive triathletes. Eur Radiol. 2020;30(5):2830&#x2013;2842. doi: 10.1007/s00330-019-06576-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-019-06576-z</ArticleId><ArticleId IdType="pubmed">31953666</ArticleId></ArticleIdList></Reference><Reference><Citation>Siperstein MD, Unger RH, Madison LL. Studies of muscle capillary basement membranes in normal subjects, diabetic, and prediabetic patients. J Clin Invest. 1968;47(9):1973&#x2013;1999. doi: 10.1172/JCI105886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI105886</ArticleId><ArticleId IdType="pmc">PMC297361</ArticleId><ArticleId IdType="pubmed">5675423</ArticleId></ArticleIdList></Reference><Reference><Citation>Carry MR, Ringel SP, Starcevich JM. Distribution of capillaries in normal and diseased human skeletal muscle. Muscle Nerve. 1986;9(5):445&#x2013;454. doi: 10.1002/mus.880090510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880090510</ArticleId><ArticleId IdType="pubmed">2941685</ArticleId></ArticleIdList></Reference><Reference><Citation>Global burden of disease long, C C, et al. (2022) Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA 328(16): 1604&#x2013;1615</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Cullinan J, et al. Understanding the economic impact of myalgic encephalomyelitis/chronic fatigue syndrome in Ireland: a qualitative study. HRB Open Res. 2020;3:88. doi: 10.12688/hrbopenres.13181.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/hrbopenres.13181.1</ArticleId><ArticleId IdType="pmc">PMC7898356</ArticleId><ArticleId IdType="pubmed">33659857</ArticleId></ArticleIdList></Reference><Reference><Citation>Hejbol EK, et al. Myopathy as a cause of fatigue in long-term post-COVID-19 symptoms: evidence of skeletal muscle histopathology. Eur J Neurol. 2022;29(9):2832&#x2013;2841. doi: 10.1111/ene.15435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15435</ArticleId><ArticleId IdType="pmc">PMC9348124</ArticleId><ArticleId IdType="pubmed">35661354</ArticleId></ArticleIdList></Reference><Reference><Citation>Enax-Krumova E, et al. Quantitative muscle MRI depicts microstructural abnormalities but no signs of inflammation or dystrophy in Post COVID-19 condition. Eur J Neurol. 2023;30(4):970&#x2013;981. doi: 10.1111/ene.15709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15709</ArticleId><ArticleId IdType="pubmed">36693812</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu H, et al. New-onset dermatomyositis following COVID-19: a case report. Front Immunol. 2022;13:1002329. doi: 10.3389/fimmu.2022.1002329.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1002329</ArticleId><ArticleId IdType="pmc">PMC9637802</ArticleId><ArticleId IdType="pubmed">36353621</ArticleId></ArticleIdList></Reference><Reference><Citation>Loghman M, et al. Necrotizing autoimmune myositis following coronavirus disease 2019 infection: a case report. J Med Case Rep. 2022;16(1):488. doi: 10.1186/s13256-022-03680-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13256-022-03680-5</ArticleId><ArticleId IdType="pmc">PMC9793820</ArticleId><ArticleId IdType="pubmed">36575546</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschman T, Stenzel W. COVID-19 associated myopathy. Curr Opin Neurol. 2022;35(5):622&#x2013;628. doi: 10.1097/WCO.0000000000001101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000001101</ArticleId><ArticleId IdType="pubmed">35950722</ArticleId></ArticleIdList></Reference><Reference><Citation>Graf M, et al. SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathies. RMD Open. 2022;8(1):e001934. doi: 10.1136/rmdopen-2021-001934.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rmdopen-2021-001934</ArticleId><ArticleId IdType="pmc">PMC8860073</ArticleId><ArticleId IdType="pubmed">35177553</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgoin P, et al. Role of the interferons in CD64 and CD169 expressions in whole blood: relevance in the balance between viral- or bacterial-oriented immune responses. Immun Inflamm Dis. 2020;8(1):106&#x2013;123. doi: 10.1002/iid3.289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.289</ArticleId><ArticleId IdType="pmc">PMC7016842</ArticleId><ArticleId IdType="pubmed">32031762</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Addio M, et al. Sialoglycans on lymphatic endothelial cells augment interactions with Siglec-1 (CD169) of lymph node macrophages. FASEB J. 2021;35(11):e22017. doi: 10.1096/fj.202100300R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202100300R</ArticleId><ArticleId IdType="pubmed">34699642</ArticleId></ArticleIdList></Reference><Reference><Citation>Asano K, Kikuchi K, Tanaka M. CD169 macrophages regulate immune responses toward particulate materials in the circulating fluid. J Biochem. 2018;164(2):77&#x2013;85. doi: 10.1093/jb/mvy050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jb/mvy050</ArticleId><ArticleId IdType="pubmed">29905851</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu HC, et al. Deficiency of the B cell-activating factor receptor results in limited CD169+ macrophage function during viral infection. J Virol. 2015;89(9):4748&#x2013;4759. doi: 10.1128/JVI.02976-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02976-14</ArticleId><ArticleId IdType="pmc">PMC4403498</ArticleId><ArticleId IdType="pubmed">25673724</ArticleId></ArticleIdList></Reference><Reference><Citation>Doehn JM, et al. CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity. Infection. 2021;49(4):757&#x2013;762. doi: 10.1007/s15010-021-01606-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01606-9</ArticleId><ArticleId IdType="pmc">PMC8023546</ArticleId><ArticleId IdType="pubmed">33825125</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Gonzalo R, et al. Three months of bed rest induce a residual transcriptomic signature resilient to resistance exercise countermeasures. FASEB J. 2020;34(6):7958&#x2013;7969. doi: 10.1096/fj.201902976R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201902976R</ArticleId><ArticleId IdType="pubmed">32293758</ArticleId></ArticleIdList></Reference><Reference><Citation>McFarland AJ, et al. RNA sequencing on muscle biopsy from a 5-week bed rest study reveals the effect of exercise and potential interactions with dorsal root ganglion neurons. Physiol Rep. 2022;10(3):e15176. doi: 10.14814/phy2.15176.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.15176</ArticleId><ArticleId IdType="pmc">PMC8823189</ArticleId><ArticleId IdType="pubmed">35133080</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopard A, et al. Large-scale mRNA analysis of female skeletal muscles during 60 days of bed rest with and without exercise or dietary protein supplementation as countermeasures. Physiol Genomics. 2009;38(3):291&#x2013;302. doi: 10.1152/physiolgenomics.00036.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiolgenomics.00036.2009</ArticleId><ArticleId IdType="pubmed">19470803</ArticleId></ArticleIdList></Reference><Reference><Citation>Urso ML, et al. Analysis of human skeletal muscle after 48 h immobilization reveals alterations in mRNA and protein for extracellular matrix components. J Appl Physiol. 2006;101(4):1136&#x2013;1148. doi: 10.1152/japplphysiol.00180.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00180.2006</ArticleId><ArticleId IdType="pubmed">16763108</ArticleId></ArticleIdList></Reference><Reference><Citation>Montero D, et al. Increased capillary density in skeletal muscle is not associated with impaired insulin sensitivity induced by bed rest in healthy young men. Appl Physiol Nutr Metab. 2018;43(12):1334&#x2013;1340. doi: 10.1139/apnm-2018-0195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/apnm-2018-0195</ArticleId><ArticleId IdType="pubmed">29920224</ArticleId></ArticleIdList></Reference><Reference><Citation>Reidy PT, et al. Aging-related effects of bed rest followed by eccentric exercise rehabilitation on skeletal muscle macrophages and insulin sensitivity. Exp Gerontol. 2018;107:37&#x2013;49. doi: 10.1016/j.exger.2017.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2017.07.001</ArticleId><ArticleId IdType="pmc">PMC5762440</ArticleId><ArticleId IdType="pubmed">28705613</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, et al. Effects of exercise training intensity and duration on skeletal muscle capillarization in healthy subjects: a meta-analysis. Med Sci Sports Exerc. 2022;54(10):1714&#x2013;1728. doi: 10.1249/MSS.0000000000002955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/MSS.0000000000002955</ArticleId><ArticleId IdType="pubmed">35522254</ArticleId></ArticleIdList></Reference><Reference><Citation>McCully KK, Natelson BH. Impaired oxygen delivery to muscle in chronic fatigue syndrome. Clin Sci. 1999;97(5):603&#x2013;608. doi: 10.1042/cs0970603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/cs0970603</ArticleId><ArticleId IdType="pubmed">10545311</ArticleId></ArticleIdList></Reference><Reference><Citation>Franklin JD, et al. Peak oxygen uptake in chronic fatigue syndrome/myalgic encephalomyelitis: a meta-analysis. Int J Sports Med. 2019;40(2):77&#x2013;87. doi: 10.1055/a-0802-9175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-0802-9175</ArticleId><ArticleId IdType="pubmed">30557887</ArticleId></ArticleIdList></Reference><Reference><Citation>Tirelli U, et al. Patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) greatly improved fatigue symptoms when treated with oxygen-ozone autohemotherapy. J Clin Med. 2021;11(1):29. doi: 10.3390/jcm11010029.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11010029</ArticleId><ArticleId IdType="pmc">PMC8745272</ArticleId><ArticleId IdType="pubmed">35011770</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel J, et al. The SARS-CoV-2 main protease M(pro) causes microvascular brain pathology by cleaving NEMO in brain endothelial cells. Nat Neurosci. 2021;24(11):1522&#x2013;1533. doi: 10.1038/s41593-021-00926-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00926-1</ArticleId><ArticleId IdType="pmc">PMC8553622</ArticleId><ArticleId IdType="pubmed">34675436</ArticleId></ArticleIdList></Reference><Reference><Citation>Aid M, et al. Vascular disease and thrombosis in SARS-CoV-2-infected rhesus macaques. Cell. 2020;183(5):1354&#x2013;1366. doi: 10.1016/j.cell.2020.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.005</ArticleId><ArticleId IdType="pmc">PMC7546181</ArticleId><ArticleId IdType="pubmed">33065030</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso P, et al. Circulating endothelial progenitors are increased in COVID-19 patients and correlate with SARS-CoV-2 RNA in severe cases. J Thromb Haemost. 2020;18(10):2744&#x2013;2750. doi: 10.1111/jth.15044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15044</ArticleId><ArticleId IdType="pmc">PMC7436444</ArticleId><ArticleId IdType="pubmed">32762140</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaoka-Tojo M. Endothelial glycocalyx damage as a systemic inflammatory microvascular endotheliopathy in COVID-19. Biomed J. 2020;43(5):399&#x2013;413. doi: 10.1016/j.bj.2020.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bj.2020.08.007</ArticleId><ArticleId IdType="pmc">PMC7443638</ArticleId><ArticleId IdType="pubmed">33032965</ArticleId></ArticleIdList></Reference><Reference><Citation>Natalello G, et al. Nailfold capillaroscopy findings in patients with coronavirus disease 2019: broadening the spectrum of COVID-19 microvascular involvement. Microvasc Res. 2021;133:104071. doi: 10.1016/j.mvr.2020.104071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2020.104071</ArticleId><ArticleId IdType="pmc">PMC7494493</ArticleId><ArticleId IdType="pubmed">32949574</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffke M, et al. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) J Transl Med. 2022;20(1):138. doi: 10.1186/s12967-022-03346-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03346-2</ArticleId><ArticleId IdType="pmc">PMC8938726</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>Smatti MK, et al. Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms. Viruses. 2019;11(8):762. doi: 10.3390/v11080762.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11080762</ArticleId><ArticleId IdType="pmc">PMC6723519</ArticleId><ArticleId IdType="pubmed">31430946</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjornevik K, et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022;375(6578):296&#x2013;301. doi: 10.1126/science.abj8222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abj8222</ArticleId><ArticleId IdType="pubmed">35025605</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff MC, et al. Dysregulated naive B cells and de novo autoreactivity in severe COVID-19. Nature. 2022;611(7934):139&#x2013;147. doi: 10.1038/s41586-022-05273-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05273-0</ArticleId><ArticleId IdType="pmc">PMC9630115</ArticleId><ArticleId IdType="pubmed">36044993</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunez-Castilla J, et al. Potential autoimmunity resulting from molecular mimicry between SARS-CoV-2 spike and human proteins. Viruses. 2022;14(7):1415. doi: 10.3390/v14071415.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14071415</ArticleId><ArticleId IdType="pmc">PMC9318917</ArticleId><ArticleId IdType="pubmed">35891400</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A, Kharrazian D. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol. 2020;217:108480. doi: 10.1016/j.clim.2020.108480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108480</ArticleId><ArticleId IdType="pmc">PMC7246018</ArticleId><ArticleId IdType="pubmed">32461193</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595(7866):283&#x2013;288. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere JJ, et al. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery. Sci Transl Med. 2022;14(664):eabq3059. doi: 10.1126/scitranslmed.abq3059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abq3059</ArticleId><ArticleId IdType="pmc">PMC9210449</ArticleId><ArticleId IdType="pubmed">35857629</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C, et al. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun. 2022;13(1):446. doi: 10.1038/s41467-021-27797-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27797-1</ArticleId><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Bovenkamp FS, et al. Circulating C1q levels in health and disease, more than just a biomarker. Mol Immunol. 2021;140:206&#x2013;216. doi: 10.1016/j.molimm.2021.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2021.10.010</ArticleId><ArticleId IdType="pubmed">34735869</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalder T, et al. Development of a fatigue scale. J Psychosom Res. 1993;37(2):147&#x2013;153. doi: 10.1016/0022-3999(93)90081-P.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3999(93)90081-P</ArticleId><ArticleId IdType="pubmed">8463991</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Qual Life Res. 2011;20(10):1727&#x2013;1736. doi: 10.1007/s11136-011-9903-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-011-9903-x</ArticleId><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikell CB, et al. Muscle and nerve biopsies: techniques for the neurologist and neurosurgeon. Clin Neurol Neurosurg. 2013;115(8):1206&#x2013;1214. doi: 10.1016/j.clineuro.2013.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2013.05.008</ArticleId><ArticleId IdType="pubmed">23769866</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfel R, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581(7809):465&#x2013;469. doi: 10.1038/s41586-020-2196-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2196-x</ArticleId><ArticleId IdType="pubmed">32235945</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24(2):168&#x2013;175. doi: 10.1038/s41593-020-00758-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Preusse C, et al. Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis. Acta Neuropathol Commun. 2016;4(1):45. doi: 10.1186/s40478-016-0308-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0308-5</ArticleId><ArticleId IdType="pmc">PMC4847347</ArticleId><ArticleId IdType="pubmed">27121733</ArticleId></ArticleIdList></Reference><Reference><Citation>Baum O, Bigler M. Pericapillary basement membrane thickening in human skeletal muscles. Am J Physiol Heart Circ Physiol. 2016;311(3):H654&#x2013;H666. doi: 10.1152/ajpheart.00048.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00048.2016</ArticleId><ArticleId IdType="pubmed">27371680</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigler M, et al. Morphometry of skeletal muscle capillaries: the relationship between capillary ultrastructure and ageing in humans. Acta Physiol (Oxf) 2016;218(2):98&#x2013;111. doi: 10.1111/apha.12709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apha.12709</ArticleId><ArticleId IdType="pubmed">27174490</ArticleId></ArticleIdList></Reference><Reference><Citation>Baum O, et al. Structural microangiopathies in skeletal muscle related to systemic vascular pathologies in humans. Front Physiol. 2020;11:28. doi: 10.3389/fphys.2020.00028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.00028</ArticleId><ArticleId IdType="pmc">PMC7013089</ArticleId><ArticleId IdType="pubmed">32116748</ArticleId></ArticleIdList></Reference><Reference><Citation>Baum O, et al. Phenotype of capillaries in skeletal muscle of nNOS-knockout mice. Am J Physiol Regul Integr Comp Physiol. 2013;304(12):R1175&#x2013;R1182. doi: 10.1152/ajpregu.00434.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.00434.2012</ArticleId><ArticleId IdType="pubmed">23576613</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkhart JM, et al. Systematic and quantitative comparison of digest efficiency and specificity reveals the impact of trypsin quality on MS-based proteomics. J Proteomics. 2012;75(4):1454&#x2013;1462. doi: 10.1016/j.jprot.2011.11.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jprot.2011.11.016</ArticleId><ArticleId IdType="pubmed">22166745</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D, et al. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019;37(8):907&#x2013;915. doi: 10.1038/s41587-019-0201-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-019-0201-4</ArticleId><ArticleId IdType="pmc">PMC7605509</ArticleId><ArticleId IdType="pubmed">31375807</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaidatzis D, et al. QuasR: quantification and annotation of short reads in R. Bioinformatics. 2015;31(7):1130&#x2013;1132. doi: 10.1093/bioinformatics/btu781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu781</ArticleId><ArticleId IdType="pmc">PMC4382904</ArticleId><ArticleId IdType="pubmed">25417205</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy DJ, Chen Y, Smyth GK. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res. 2012;40(10):4288&#x2013;4297. doi: 10.1093/nar/gks042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks042</ArticleId><ArticleId IdType="pmc">PMC3378882</ArticleId><ArticleId IdType="pubmed">22287627</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523. doi: 10.1038/s41467-019-09234-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09234-6</ArticleId><ArticleId IdType="pmc">PMC6447622</ArticleId><ArticleId IdType="pubmed">30944313</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. doi: 10.1186/s13059-014-0550-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>